Open Orphan due diligence completed by Liberum Capital - DirectorsTalk Interviews
Open Orphan due diligence completed by Liberum Capital
Source: directorstalkinterviews.com
Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Open Orphan due diligence completed by Liberum Capital
Further Expansion of IP Portfolio Enhancing Protection of Poolbeg's Growing PipelineLONDON, UK / ACCESSWIRE / May 26, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical
Open Orphan to publish full year results on 7 June 2022
Yamin Khan, chief executive at Open Orphan, joined Katie to talk about Hvivo, a subsidiary of Open Orphan, signing a multi-million pound influenza human...
Open Orphan's hVIVO wins a £7.3m influenza human challenge study